Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Maintaining momentum mid month requires steady approaches. Discover ways to keep your budget on track mid month and stay aligned with goals.
25,694 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
A recent sale of 25,000 ALHC shares by Alignment Healthcare’s vice chairman has investors wondering about the stock’s...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
Figure Technology Solutions stock captured attention with a double‑digit jump in a shortened week. This article break...
A solid earnings beat doesn’t always lift a stock. This guide examines why Tutor Perini stock dropped today and what ...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
Credit investors are increasingly worried about an AI bubble. A Bank of America survey shows the concern rising fast,...
Aflac has a remarkable 43-year streak of raising its dividend, a hallmark many income investors look for. But that st...
Circle Internet Group sparked a strong move in the market as investors welcomed a robust quarterly report. This artic...
As AI expands, the backbone—data centers and compute—becomes a focal point for investors. This guide compares CoreWea...
Ethereum is showing real strength, rising sharply as momentum builds. In this guide, we break down the catalysts, ris...
A sizable $12 million stake in a floor-and-decor retailer arrives as the stock trades off. This article breaks down t...